Clinical Trials on 3 Dimensional
Total 609 results
-
RDC Clinical Pty LtdCompletedOptimal Gastrointestinal Absorption of Omega-3Australia
-
University of TalcaUniversidad de los Andes, ChileNot yet recruitingGeneral Population of Children Aged 3 to 5 Years Old
-
Innovative MedicalUnknownPatients Who Have Bilateral NanoFlex Implantation at Least 3 Months PreviouslyUnited States
-
Josip Juraj Strossmayer University of OsijekRecruitingn-3 Polyunsaturated Fatty AcidsCroatia
-
University of East AngliaQuadram Institute BioscienceCompletedMetabolism and Clearance of Cyanidin 3 GlucosideUnited Kingdom
-
Universitaire Ziekenhuizen KU LeuvenCompletedCondition of Patient 3 Years After FESS-operationBelgium
-
Gdansk University of Physical Education and SportUniversity of Southampton; Medical University of GdanskCompletedEffect of Omega-3 Supplementation on Exercise Performance and Muscle Tissue FunctionsPoland
-
Beijing Luhe HospitalUnknownPrinting, Three-Dimensional, Simulation TrainingChina
-
Acibadem UniversityCompletedLaryngeal Dimensions in Males and Females
-
Cairo UniversityUnknownTo Assess Bucco-lingual Dimension of the Ridge While Using Pontic Shield Technique as a Treatment Modality for Ridge PreservationEgypt
-
Centre Hospitalier Universitaire de NiceCompletedAdult Chronic Haemodialysis Patients Since at Least 3 MonthsFrance
-
Allievex CorporationCompletedMucopolysaccharidosis Type IIIB | Mucopolysaccharidosis Type 3 B | MPS III B | MPS 3 BUnited States, Spain, Turkey, Taiwan, Australia, Colombia, Germany, United Kingdom
-
University of MalayaUnknownTranspalatal Arch (TPA) | Oral Health Related Quality of Life (OHRQoL) | Oral Health Impact Profile Short Version 14 (OHIP 14) | Orthodontic Pain | Three Dimensional (3D) Orthodontic DeviceMalaysia
-
King Abdulaziz UniversityCompletedEffect of Carriere® Motion™ Appliance on Pharyngeal Airway Dimensions | Effect of Carriere® Motion™ Appliance on Skeletal and Dental MeasurementsSaudi Arabia
-
Wael Elbanna ClinicFetal Medicine Research Center, SpainRecruitingWomen Conceiving by: 1- ICSI-PGS 2- ICSI-non-PGS 3- Spontaneously Conceiving WomenEgypt
-
Radboud University Medical CenterCompletedTooth Wear | Randomized Controlled Trial | Composite Resins | Vertical Dimension of OcclusionNetherlands
-
University of California, Los AngelesNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedHuman Papillomavirus | CIN 3 | CIN 2United States
-
Louqiang ZhangApproved for marketingMandible Fracture | Rigid Internal Fixation | Three-dimensional Finite ElementChina
-
Hallym University Kangnam Sacred Heart HospitalUnknownPatients Receiving Protective Lung Ventilation | Patients in Grey Zone (3 < Pulse Pressure Variation (PPV) < 17Korea, Republic of
-
Sohag UniversityActive, not recruitingThree-Dimensional Ultrasonography Versus Magnetic Resonance Imaging for Fibroid MappingEgypt
-
Riphah International UniversityRecruitingPlanter Fasciitis | Eccentric Heel Drop Training | 3-D Ankle MobilityPakistan
-
Mondelēz International, Inc.Reading Scientific Services Ltd.WithdrawnStudy Focus 1:Glycaemic Index | Study Focus 2:Glycaemic Response | Study Focus 3:Insulinemic ResponseUnited Kingdom
-
Fondazione Angelo Bianchi BonomiSintesi Research SrlActive, not recruitingType 3 Von Willebrand's DiseaseFinland, France, Germany, Hungary, Iran, Islamic Republic of, Italy, Netherlands, Spain, Sweden, United Kingdom
-
VA Office of Research and DevelopmentActive, not recruitingBenzodiazepine Dependence | Taking Benzodiazepines for Any Reason for 3 MonthsUnited States
-
Poitiers University HospitalActive, not recruitingSchatzker Type 2 or 3 Tibial Plateau FractureFrance, Martinique
-
October 6 UniversityCompletedPeriodontitis (Stage 3)Egypt
-
National Taiwan University HospitalCompletedPatients Admitted to the ICU More Than 3 Days Post-onsetTaiwan
-
University of JordanCompletedDiagnosis of GHD With IGF-I/IGFBP-3 Ratio
-
Chinese University of Hong KongCompleted
-
Chinese University of Hong KongCompletedTriage Category 3 (Urgent)Hong Kong
-
Apellis Pharmaceuticals, Inc.AvailableC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Spain, France, Germany, United Kingdom, Netherlands, Brazil, Israel, Japan, Australia, Austria, Italy, Switzerland, Korea, Republic of, Czechia, Belgium, Argentina, Canada, Poland
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Australia, Brazil, Czechia, France, Italy, Korea, Republic of, Netherlands, Spain, Switzerland, United Kingdom
-
University of ZurichTerminatedDiastasis Recti | Interrectal Distance | Dimensions of the Muscles of the Lateral Abdominal WallSwitzerland
-
OFFHEALTH S.p.A.Not yet recruiting
-
PepsiCo Global R&DUnknownChange in Cognitive Function and Fatigue During Extended Performance of the Cognitive Demand Battery (CDB) at 1, 3 and 6 Hours Post Consumption | Change in Long Term Declarative Memory at 1, 3 and 6 Hours Post-intervention.United Kingdom
-
Holbaek SygehusOdense University HospitalUnknownStability of Clavicular Fractures Within the First 3 WeeksDenmark
-
St George's, University of LondonCompletedCKd Patients With Stage 3 and 4
-
University of AberdeenNHS Grampian; Chief Scientist Office of the Scottish GovernmentCompletedStage 2 or 3 Full Thickness Macular HoleUnited Kingdom, Ireland
-
Massachusetts General HospitalNational Cancer Institute (NCI)Active, not recruitingLow Grade Glioma | WHO Grade 3 Glioma With IDH1 Mutation | WHO Grade 3 Glioma With 1p/19q CodeletionUnited States
-
University Hospital Inselspital, BerneUMC Utrecht; Cliniques universitaires Saint-Luc- Université Catholique de Louvain and other collaboratorsCompleted3 or More Chronic Conditions for 6 Months or Longer | 5 or More Regular DrugsBelgium, Ireland, Netherlands, Switzerland
-
Al-Azhar UniversityCompletedSkeletal Class 3 Malocclusion Due to Maxillary DeficiencyEgypt
-
University Hospital Inselspital, BerneUMC Utrecht; Cliniques universitaires Saint-Luc- Université Catholique de Louvain and other collaboratorsCompletedOPtimising thERapy to Prevent Avoidable Hospital Admissions in the Multimorbid Older People (OPERAM)3 or More Chronic Conditions for 6 Months or Longer | 5 or More Regular DrugsBelgium, Ireland, Netherlands, Switzerland
-
Yonsei UniversityCompletedModerate and Severe Meibomiang Gland Dysfunction (Stage 3 or Stage 4 Meibomiang Gland Dysfunction)Korea, Republic of
-
University of BernNot yet recruitingComplications | Patient Reported Outcome Measures | Cost-Benefit Analysis | Cost-effectiveness | Esthetic Zone | Single Tooth Dental Implant | Single Tooth Lost | Accuracy of Dental Implants | Dimensional Changes | Implant Survival and Success | Frequency of Treatment ProtocolSwitzerland
-
Yooyoung Pharmaceutical Co., Ltd.CompletedWrinkle Severity Rating Scale(WSRS) Grade 3 (Moderate) or 4 (Severe) of Nasolabial FoldsKorea, Republic of
-
AquaPass Medical Ltd.Not yet recruitingChronic Heart Failure | CKD Stage 3Israel, United States
-
Denver Health and Hospital AuthorityMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.CompletedModerate Alcohol Consumption (1-3 Drinks Per Day)
-
Memorial Sloan Kettering Cancer CenterChugai Pharma USARecruitingPrimary Extra-cranial Solid Tumor | Recurrent or Refractory Glypican 3 (GPC3)United States
-
Apellis Pharmaceuticals, Inc.Active, not recruitingRenal Transplant | C3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative... and other conditionsUnited States, Australia, Austria, United Kingdom, Brazil, Argentina, France, Italy, Netherlands, Spain, Switzerland